{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "84755-0010",
      "generic_name": "KRX Aesthetics PD-13 Therapy",
      "labeler_name": "KRX RESOURCES SDN. BHD.",
      "brand_name": "KRX Aesthetics PD-13 Therapy",
      "active_ingredients": [
        {
          "name": "METHYL AMINOLEVULINATE HYDROCHLORIDE",
          "strength": "1.95 mg/15mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "84755-0010-1",
          "description": "15 mL in 1 PACKAGE (84755-0010-1)",
          "marketing_start_date": "20260101",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "KRX RESOURCES SDN. BHD."
        ],
        "spl_set_id": [
          "4e6af886-2e2e-0343-e063-6394a90ad095"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "7S73606O1A"
        ]
      },
      "marketing_category": "UNAPPROVED DRUG OTHER",
      "dosage_form": "SPRAY",
      "spl_id": "4e6af886-2e2f-0343-e063-6394a90ad095",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "TOPICAL"
      ],
      "marketing_start_date": "20260101",
      "product_id": "84755-0010_4e6af886-2e2f-0343-e063-6394a90ad095",
      "brand_name_base": "KRX Aesthetics PD-13 Therapy",
      "pharm_class": [
        "Porphyrin Precursor [EPC]",
        "Porphyrinogens [CS]"
      ]
    }
  ]
}